“EUSOBI provides an excellent opportunity for breast radiologists with a specialist interest in imaging, to learn about the latest developments in this field, as well as get hands-on-experience on the latest technology and approaches” said Anna Eriksrud, CEO.
The company recently received approval from the US Food and Drug Administration, which is a major milestone for the company. The focus on Europe is still very important for NeoDynamics, as it continues to challenge conventional approaches in breast imaging. EUSOBI is an excellent platform for NeoDynamics, to access and engage with key physicians in Europe. NeoDynamics will feature in this year’s programme offering a workshop for attendees, where they can use the device. It is this hands-on-experience which really highlights the benefits of the device to the user and patient.